Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F22%3A73614939" target="_blank" >RIV/61989592:15110/22:73614939 - isvavai.cz</a>
Alternative codes found
RIV/00098892:_____/22:10157765 RIV/68081707:_____/22:00584489
Result on the web
<a href="https://www.linkos.cz/files/klinicka-onkologie/513/6140.pdf" target="_blank" >https://www.linkos.cz/files/klinicka-onkologie/513/6140.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.48095/ccko2022473" target="_blank" >10.48095/ccko2022473</a>

Result language
angličtina
Original language name
Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer
Original language description
Current in vitro model systems do not fully reflect the biological and clinical diversity of prostate cancer (PCa). Organoids are 3D in vitro cell cultures that may better recapitulate disease heterogeneity and retain parental tumor characteristics. Short-term ex vivo culture of PCa tissues may also facilitate drug testing in personalized medicine.
Czech name
—
Czech description
—

Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
30204 - Oncology

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)